Constance Bart-Plange
University of Ghana
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Constance Bart-Plange.
BMC Public Health | 2010
Kwaku Poku Asante; Livesy Abokyi; Charles Zandoh; Ruth Owusu; Elizabeth Awini; Abubakari Sulemana; Seeba Amenga-Etego; Robert Adda; Owusu Boahen; Sylvester Segbaya; Emmanuel Mahama; Constance Bart-Plange; Daniel Chandramohan; Seth Owusu-Agyei
BackgroundArtesunate-amodiaquine (AS-AQ) was introduced in Ghana as the first line drug for treatment of uncomplicated malaria in 2004. We report the perceptions of malaria and malaria treatment behaviour, the community awareness of and perceptions about AS-AQ two years after the introduction of this ACT treatment for malaria.MethodsTwo surveys were conducted; a cross-sectional survey of 729 randomly selected household heads (urban-362, rural-367) and 282 women with children < 5 years (urban-121, rural-161) was conducted in 2006. A district wide survey was conducted in 2007 to assess awareness of AS-AQ. These were complemented with twenty-eight focus group discussions (FGDs) and 16 key informant interviews (KII) among community members and major stakeholders in the health care delivery services. All nine (9) health facilities and five (5) purposively selected drug stores were audited in order to identify commonly used anti-malarials in the study area at the time of the survey.ResultsMajority of respondents ( > 75%) in the sampled survey mentioned mosquito bites as the cause of malaria. Other causes mentioned include environmental factors (e.g. dirty surroundings) and standing in the sun. Close to 60% of the household heads and 40% of the care-givers interviewed did not know about AS-AQ. The community respondents who knew about and had ever taken AS-AQ perceived it to be a good drug; although they mentioned they had experienced some side effects including headaches and body weakness. Co-blistered AS-AQ was available in all the government health facilities in the study area. Different formulations of ACTs were however found in urban chemical shops but not in rural chemical stores where monotherapy antimalarials were predominant.ConclusionThe knowledge of fever as a symptom of malaria is high among the study population. The awareness of AS-AQ therapy and its side-effect was low in the study area. Community education and sensitization, targeting all categories of the population, has to be intensified to ensure an efficient implementation process.
Malaria Journal | 2014
Lucy Smith Paintain; Elizabeth Awini; Sheila Addei; Vida Kukula; Christian Nikoi; Doris Sarpong; Alfred Kwesi Manyei; Daniel Yayemain; Etienne Rusamira; Josephine Agborson; Aba Baffoe-Wilmot; Constance Bart-Plange; Anirban Chatterjee; Margaret Gyapong; Lindsay Mangham-Jefferies
BackgroundBetween May 2010 and October 2012, approximately 12.5 million long-lasting insecticidal nets (LLINs) were distributed through a national universal mass distribution campaign in Ghana. The campaign included pre-registration of persons and sleeping places, door-to-door distribution of LLINs with ‘hang-up’ activities by volunteers and post-distribution ‘keep-up’ behaviour change communication activities. Hang-up activities were included to encourage high and sustained use.MethodsThe cost and cost-effectiveness of the LLIN Campaign were evaluated using a before-after design in three regions: Brong Ahafo, Central and Western. The incremental cost effectiveness of the ‘hang-up’ component was estimated using reported variation in the implementation of hang-up activities and LLIN use. Economic costs were estimated from a societal perspective assuming LLINs would be replaced after three years, and included the time of unpaid volunteers and household contributions given to volunteers.ResultsAcross the three regions, 3.6 million campaign LLINs were distributed, and 45.5% of households reported the LLINs received were hung-up by a volunteer. The financial cost of the campaign was USD 6.51 per LLIN delivered. The average annual economic cost was USD 2.90 per LLIN delivered and USD 6,619 per additional child death averted by the campaign. The cost-effectiveness of the campaign was sensitive to the price, lifespan and protective efficacy of LLINs.Hang-up activities constituted 7% of the annual economic cost, though the additional financial cost was modest given the use of volunteers. LLIN use was greater in households in which one or more campaign LLINs were hung by a volunteer (OR = 1.57; 95% CI = 1.09, 2.27; p = 0.02). The additional economic cost of the hang-up activities was USD 0.23 per LLIN delivered, and achieved a net saving per LLIN used and per death averted.ConclusionIn this campaign, hang-up activities were estimated to be net saving if hang-up increased LLIN use by 10% or more. This suggests hang-up activities can make a LLIN campaign more cost-effective.
Journal of Public Health Policy | 2013
Keziah L. Malm; Sylvester Segbaya; Kwame Gakpey; Lily Boatemaa Sampong; Eunice Achiaa Adjei; Constance Bart-Plange
In 2004, Ghana adopted Artemisinin-based Combination Therapy (ACT) for the treatment of uncomplicated malaria. The use of ACTs had been low, especially in the private sector, because of higher prices of ACTs. The Affordable Medicine Facility for Malaria Initiative, in which international organizations subsidize ACTs to make them affordable locally, is being implemented in Ghana. We document the processes, challenges, and achievements of this initiative in Ghana based on a review of policies, guidelines, reports, meeting minutes, and an internet search. The review spanned activities from July 2009 to December 2011. Ghana was the first country to receive these subsidized ACTs (called ‘co-paid’), and availability of ACTs increased from 31 per cent to 83 per cent nationwide. The price of ACTs dropped from about US
Parasites & Vectors | 2016
Kwame Gakpey; Aba Baffoe-Wilmot; Keziah L. Malm; Samuel Dadzie; Constance Bart-Plange
7 to
PLOS ONE | 2015
Ruth Owusu; Kwaku Poku Asante; Emmanuel Mahama; Elizabeth Awini; Thomas Anyorigiya; David Dosoo; Alberta Amu; Gabriel Jakpa; Emmanuel Ofei; Sylvester Segbaya; Abraham Oduro; Margaret Gyapong; Abraham Hodgson; Constance Bart-Plange; Seth Owusu-Agyei
0.75 for adults and from
Cost Effectiveness and Resource Allocation | 2018
Theresa Tawiah; Keziah Malam; Anthony Kwarteng; Constance Bart-Plange; Lawrence Gyabaa Febir; Vivian N. Ama Aubyn; Konrad Obermann; Seth Owusu-Agyei; Kwaku Poku Asante
5 to
Global Health Action | 2017
Timothy Awine; Keziah Malm; Constance Bart-Plange; Sheetal P. Silal
0.5 for children. Misuse of anti-malarials so that they fail to improve health and can spread resistance may occur if the initiative is not well managed. Collaboration with stakeholders, especially the private sector, and implementation of appropriate supportive activities is important with this initiative.
BMC Public Health | 2017
Blanca Escribano-Ferrer; Margaret Gyapong; Jane Bruce; Solomon A. Narh Bana; Clement T. Narh; Naa-Korkor Allotey; Roland Glover; Charity Azantilow; Constance Bart-Plange; Isabella Sagoe-Moses; Jayne Webster
Long lasting Insecticidal nets continue to provide effective protection against disease vectors including mosquitoes that transmit malaria. In many countries, promotion of LLIN usage and ownership has focused on the attainment of universal coverage. However modalities for achieving these objectives remain a challenge in many countries. This paper shares Ghana’s experience and strategies adopted to attain universal LLINs coverage.
Health Policy and Planning | 2012
Don de Savigny; Jayne Webster; Irene Akua Agyepong; Alex Mwita; Constance Bart-Plange; Aba Baffoe-Wilmot; Hannah Koenker; Karen Kramer; Nick Brown; Christian Lengeler
Background Sulphadoxine-Pyrimethamine (SP) is still the only recommended antimalarial for use in intermittent preventive treatment of malaria during pregnancy (IPTp) in some malaria endemic countries including Ghana. SP has the potential to cause acute haemolysis in G6PD deficient people resulting in significant haemoglobin (Hb) drop but there is limited data on post SP-IPTp Hb drop. This study determined the difference, if any in proportions of women with significant acute haemoglobin drop between G6PD normal, partial deficient and full deficient women after SP-IPTp. Methods and Findings Prospectively, 1518 pregnant women who received SP for IPTp as part of their normal antenatal care were enrolled. Their G6PD status were determined at enrollment followed by assessments on days 3, 7,14 and 28 to document any adverse effects and changes in post-IPTp haemoglobin (Hb) levels. The three groups were comparable at baseline except for their mean Hb (10.3 g/dL for G6PD normal, 10.8 g/dL for G6PD partial deficient and 10.8 g/dL for G6PD full defect women).The prevalence of G6PD full defect was 2.3% and 17.0% for G6PD partial defect. There was no difference in the proportions with fractional Hb drop ≥ 20% as compared to their baseline value post SP-IPTp among the 3 groups on days 3, 7, 14. The G6PD full defect group had the highest median fractional drop at day 7. There was a weak negative correlation between G6PD activity and fractional Hb drop. There was no statistical difference between the three groups in the proportions of those who started the study with Hb ≥ 8g/dl whose Hb level subsequently fell below 8g/dl post-SP IPTp. No study participant required transfusion or hospitalization for severe anaemia. Conclusions There was no significant difference between G6PD normal and deficient women in proportions with significant acute haemoglobin drop post SP-IPTp and lower G6PD enzyme activity was not strongly associated with significant acute drug-induced haemoglobin drop post SP-IPTp but a larger study is required to confirm consistency of findings.
Malaria Journal | 2016
Benjamin Abuaku; Nancy O. Duah; Lydia Quaye; Neils B. Quashie; Keziah L. Malm; Constance Bart-Plange; Kwadwo A. Koram
BackgroundUse of malaria rapid diagnostic test (mRDT) enhances patient management and reduces costs associated with the inappropriate use of antimalarials. Despite its proven clinical effectiveness, mRDT is not readily available at licensed chemical shops in Ghana. Therefore, in order to improve the use of mRDT, there is the need to understand the willingness to pay for and sell mRDT. This study assessed patients’ willingness to pay and licensed chemical operators’ (LCS) willingness to sell mRDTs.MethodsThe study was a cross-sectional survey conducted in Kintampo North Municipality and Kintampo South District of Ghana. Contingent valuation method using the dichotomous approach was applied to explore patient’s willingness to pay. In-depth interviews (IDIs) were used to obtain information from licensed chemical operators’ willingness to sell.ResultsMajority 161 (97%) of the customers were willing to pay for mRDT while 100% of licensed chemical operators were also willing to sell mRDT. The average lowest amount respondents were willing to pay was Ghana cedis (GH¢) 1.1 (US